P K Gillman. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Central Nervous System Diseases/chemically inducedChlorpromazine/therapeutic useClomipramine/administration & dosageClomipramine/adverse effectsDepression/drug therapyDrug InteractionsHumansMonoamine Oxidase Inhibitors/administration & dosageMonoamine Oxidase Inhibitors/adverse effectsSerotonin Uptake Inhibitors/administration & dosageSerotonin Uptake Inhibitors/adverse effectsSyndromeTranylcypromine/administration & dosageTranylcypromine/adverse effects
Substances： See more » Monoamine Oxidase InhibitorsSerotonin Uptake InhibitorsTranylcypromineClomipramineChlorpromazine
Year: 1996 PMID： 8862337 DOI： 10.5694/j.1326-5377.1996.tb124999.x
Source DB: PubMed Journal: Med J Aust ISSN： 0025-729X Impact factor: 7.738